Biotech Strategy Blog

Commentary on Science, Innovation & New Products

Posts tagged ‘abiraterone’

American Urological Association Annual Meeting 2011 Satellite Symposia

By on May 12, 2011

American Urological Association Banner American Urological Association Annual Meeting 2011 Satellite SymposiaI am off to Washington DC tomorrow for the annual meeting of the American Urological Association (AUA).

If you are not able to attend, then you can follow the Twitter coverage on Pharma Strategy Blog where Sally Church (@MaverickNY) will be aggregating the tweets.  The conference hashtag is #AUA2011.  I also expect to be live-tweeting from the conference.

follow me b American Urological Association Annual Meeting 2011 Satellite Symposia

Like many medical conferences in the United States, the AUA meeting kicks off with independent continuing medical education (CME) satellite symposia on topics of interest.

This is a preview of American Urological Association Annual Meeting 2011 Satellite Symposia. Read the full post

Leave a comment

Emerging new therapies for advanced metastatic Prostate Cancer

By on March 20, 2011

EAU Vienna 2011 300x225 Emerging new therapies for advanced metastatic Prostate Cancer Today at the European Association of Urology (EAU) annual meeting in Vienna, the big news was that 2010 was a “Grand Cru” year for new treatments for advanced prostate cancer.  Not only that, but sanofi-aventis announced that they had received European marketing approval for cabazitaxel (Jevtana®) in metastatic hormone resistance prostate cancer mHRPC.

The fact that there are now several new treatments available (or expected to be available in the not too distant future) is good news for patients and physicians.

This is a preview of Emerging new therapies for advanced metastatic Prostate Cancer. Read the full post

2 Comments